Comparison of vaginal misoprostol and gemeprost as pre-treatment in first trimester pregnancy interruption.
Morgan
M
M
Stokes
H
H
D000020:Abortifacient Agents, Nonsteroidal / Q000009:adverse effects*; D000028:Abortion, Induced; D000282:Administration, Intravaginal; D000527:Alprostadil / Q000009:adverse effects / Q000031:analogs & derivatives*; D001831:Body Temperature / Q000187:drug effects; D005260:Female; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D016595:Misoprostol / Q000009:adverse effects*; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012189:Retrospective Studies
D000020:Abortifacient Agents, Nonsteroidal; D016595:Misoprostol; C021182:gemeprost; D000527:Alprostadil